All Stories

  1. CLIP2: a novel functional player in AQP5 trafficking dynamics and implications for Sjögren’s disease
  2. Identification of Connexin 26 on Extracellular Vesicles from Human Cardiomyocytes and Plasma: Novel Insights into miRNA Loading and Oxidative Injury
  3. Identification of Connexin 26 on Extracellular Vesicles from Human Cardiomyocytes and Plasma: Novel Insights into miRNA Loading and Oxidative Injury
  4. Ultrastructural and Molecular Analysis of Vascular Smooth Muscle Cells During the Switch from a Physiological to a Pathological Phenotype
  5. Dopamine-mediated autocrine inhibition of insulin secretion
  6. Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway
  7. Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
  8. Empagliflozin restores autophagy and attenuates ponatinib-induced cardiomyocyte senescence and death
  9. Effect of Combined Levothyroxine (L-T4) and 3-Iodothyronamine (T1AM) Supplementation on Memory and Adult Hippocampal Neurogenesis in a Mouse Model of Hypothyroidism
  10. Empagliflozin inhibits excessive autophagy through the AMPK/GSK3β signalling pathway in diabetic cardiomyopathy
  11. Connexin Expression in Human Minor Salivary Glands: An Immunohistochemical Microscopy Study
  12. Dysregulated insulin secretion is associated with pancreatic β‐cell hyperplasia and direct acinar‐β‐cell trans‐differentiation in partially eNOS ‐deficient mice
  13. Sex‐related differential susceptibility to ponatinib cardiotoxicity and differential modulation of the Notch1 signalling pathway in a murine model
  14. Sodium-glucose cotransporter type 2 inhibitors prevent ponatinib-induced endothelial senescence and disfunction: A potential rescue strategy
  15. Subcellular Localization of Connexin 26 in Cardiomyocytes and in Cardiomyocyte-Derived Extracellular Vesicles
  16. September 30—October 3, 2021 Virtual
  17. Ezrin Is a Novel Protein Partner of Aquaporin-5 in Human Salivary Glands and Shows Altered Expression and Cellular Localization in Sjögren’s Syndrome
  18. Unraveling Human AQP5-PIP Molecular Interaction and Effect on AQP5 Salivary Glands Localization in SS Patients
  19. Connexin 43 and Connexin 26 Involvement in the Ponatinib-Induced Cardiomyopathy: Sex-Related Differences in a Murine Model
  20. Delivery of Thyronamines (TAMs) to the Brain: A Preliminary Study
  21. Nanoparticles Based on Quaternary Ammonium Chitosan-methyl-β-cyclodextrin Conjugate for the Neuropeptide Dalargin Delivery to the Central Nervous System: An In Vitro Study
  22. Heart and liver connexin expression related to the first stage of aging: A study on naturally aged animals
  23. Aging and biomarkers: Transcriptional levels evaluation of Osteopontin/miRNA-181a axis in hepatic tissue of rats in different age ranges
  24. Evaluation of transcriptional levels of the natriuretic peptides, endothelin-1, adrenomedullin, their receptors and long non-coding RNAs in rat cardiac tissue as cardiovascular biomarkers of aging
  25. Localization of Histidine-rich Glycoprotein (HRG) in skeletal muscle
  26. The WNT Pathway Is Relevant for the BCR-ABL1-Independent Resistance in Chronic Myeloid Leukemia
  27. Phenotyping multiple subsets in Sjögren’s syndrome: a salivary proteomic SWATH-MS approach towards precision medicine
  28. Matrix metalloproteinase inhibitors prevent the release and proteolytic activity of monocyte/macrophage-derived microparticles
  29. Rho-inhibition and neuroprotective effect on rotenone-treated dopaminergic neurons in vitro
  30. Nutlin-loaded magnetic solid lipid nanoparticles for targeted glioblastoma treatment
  31. The Polycomb BMI1 Protein Is Co-expressed With CD26+ in Leukemic Stem Cells of Chronic Myeloid Leukemia
  32. Connexin 26 Expression in Mammalian Cardiomyocytes
  33. Ex Vivo and in Vivo Study of Sucrosomial® Iron Intestinal Absorption and Bioavailability
  34. Immunohistochemical localization of histidine-rich glycoprotein in human skeletal muscle: preferential distribution of the protein at the sarcomeric I-band
  35. Nanoparticles based on quaternary ammonium–chitosan conjugate: A vehicle for oral administration of antioxidants contained in red grapes
  36. Salbutamol inhibits RhoA activation in normal but not in desensitized bronchial smooth muscle cells
  37. Adenosine Receptor Transcriptomic Profile in Cardiac Tissue of a Zucker Rat Model
  38. Altered expression of connexin 43 and related molecular partners in a pig model of left ventricular dysfunction with and without dipyrydamole therapy
  39. High concentration of C-type natriuretic peptide promotes VEGF-dependent vasculogenesis in the remodeled region of infarcted swine heart with preserved left ventricular ejection fraction
  40. Impact of Obesity on the Expression Profile of Natriuretic Peptide System in a Rat Experimental Model
  41. Adenosine receptor expression in an experimental animal model of myocardial infarction with preserved left ventricular ejection fraction
  42. Altered Expression Pattern of Molecular Factors Involved in Colonic Smooth Muscle Functions: An Immunohistochemical Study in Patients with Diverticular Disease
  43. Histopathology in Gastrointestinal Neuromuscular Diseases
  44. Regional evidence of modulation of cardiac adiponectin level in dilated cardiomyopathy: pilot study in a porcine animal model
  45. Pacing-Induced Regional Differences in Adenosine Receptors mRNA Expression in a Swine Model of Dilated Cardiomyopathy
  46. Immunohistochemical analysis of myenteric ganglia and interstitial cells of Cajal in ulcerative colitis
  47. Expression of C-type natriuretic peptide and its receptor NPR-B in cardiomyocytes
  48. Effect of Laser Micromachining of Titanium on Viability and Responsiveness of Osteoblast-Like Cells
  49. Evidence that muscle cells do not express the histidine-rich glycoprotein associated with AMP deaminase but can internalise the plasma protein
  50. Glycosylation interference on RhoA activation: Focus on G-CSF
  51. The small peptide OGP(10-14) reduces proliferation and induces differentiation of TPO-primed M07-e cells through RhoA/TGFbeta1/SFK pathway
  52. Embedding methods for poly(l-lactic acid) microfiber mesh/human mesenchymal stem cell constructs
  53. Quantitative evaluation of myenteric ganglion cells in normal human left colon: implications for histopathological analysis
  54. PROCEEDINGS OF THE 33rd NATIONAL CONGRESS OF THE ITALIAN SOCIETY OF HISTOCHEMISTRY
  55. Morpho-Functional Characterization of Human Mesenchymal Stem Cells from Umbilical Cord Blood for Potential Uses in Regenerative Medicine
  56. Sortilin Is a Putative Postendocytic Receptor of Thyroglobulin
  57. Gelatin/PLLA Sponge-Like Scaffolds Allow Proliferation and Osteogenic Differentiation of Human Mesenchymal Stromal Cells
  58. Interaction of human gingival fibroblasts with PVA/gelatine sponges
  59. PS-341 (Bortezomib) inhibits proliferation and induces apoptosis of megakaryoblastic MO7-e cells
  60. PEG-Filgrastim activity on granulocyte functions
  61. Human autologous plasma-derived clot as a biological scaffold for mesenchymal stem cells in treatment of orthopedic healing
  62. TSH-Dependent Expression of the LDL Receptor–Associated Protein (RAP) in Thyroid Epithelial Cells
  63. Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon
  64. Morphological features of ovine embryonic lung fibroblasts cultured on different bioactive scaffolds
  65. Glycosylated or non-glycosylated G-CSF differently influence human granulocyte functions through RhoA
  66. Kidney Expression of RhoA, TGF-β1, and Fibronectin in Human IgA Nephropathy
  67. Thyroid dysfunction in megalin deficient mice
  68. Immunohistochemical demonstration of the small GTPase RhoA on epoxy-resin embedded sections
  69. Carboxy-terminal fragment of osteogenic growth peptide regulates myeloid differentiation through RhoA
  70. Cellular and subcellular localization of the small G protein RhoA in the human and rat embryonic and adult kidney
  71. Renal cell cultures for the study of growth factor interactions underlying kidney organogenesis
  72. TGF-Alpha mRNA Expression in Renal Organogenesis: A Study in Rat and Human Embryos
  73. A morphological study of the expression of the small G protein RhoA in resting and activated MDCK cells
  74. Use of the comet test in the evaluation of multidrug resistance of human cell lines
  75. The effect of cytokines, including IL4, IL7, stem cell factor, insulin-like growth factor on childhood acute lymphoblastic leukemia
  76. GST-7T and P-170 co-expression in multiple myeloma
  77. Evaluation of resistance index of several anticancer agents on parental and resistant P-388 cell lines
  78. Induction of multidrug resistance (MDR) by transfection of MCF-10A cell line withc-Ha-ras andc-erbB-2 oncogenes
  79. Idarubicin is active on MDR cells: evaluation of DNA synthesis inhibition on P388 cell lines
  80. Vitamin D binding protein is produced by human monocytes
  81. Multidrug Resistance and Electromagnetic Fields